Dublin, Jan. 28, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/kr66q6/pen_injection) has announced the addition of the "Pen Injection Devices" report to their offering.
User-friendly syringe and injection device designs and the availability of an increasing number of drugs in prefilled insertable and disposable cartridges are propelling the growth of pen injection devices for self-administration. The cost of biologicals such as recombinant proteins has created interest in pen injectors to reduce cost and waste associated with the handling of vial-packaged drugs. A second factor is the continued adoption of custom pen designs as a way of differentiating injectables developed for self-administration through product branding. These devices feature one or more user-friendly features to further the product's desirability relative to competing options.
What You Will Learn
- What injectable drugs are supplied in pen injection devices; what are the key market segments, market dynamics and market demographics?
- What are the therapeutic demand drivers and commercial pen products in key product segments?
- What are the design factors, material selection issues, technologies and market development issues?
- How big is the pen injection device market? How fast is it growing? What will it look like in five years?
- Who are the leading device and drug sector participants, their product development activities, business strategies, and corporate alliances and affiliations?
- What is the importance of pharma-device alliances and design partnerships on pen injection device commercialization and market access?
- What is the impact of wirelessly connected pen injection devices on patient care and market growth?
- What are the significant economic, technology, and regulatory factors affecting the market for pen injection devices?
Key Topics Covered:
1. Executive Summary
2. Injectable Drug Sector Market Dynamics
- The Injectable Drug Ecosystem
- Drug Classes and Devices
- Indications and Demand
- The Pen Injection Device Market
- Device Growth Factors
- Biological Drugs Proliferating
- Growth of Self-Administration
- Shifting Demographics
- Device Design Innovation
- Competitive Landscape
- Risk Factors
3. Pen Injection Device Design Factors
- Standardized Pen Platforms
- Custom Pen Designs
- Reusable Pens
- Prefilled Pen Cartridges
- Disposable Pens
- Dual Chamber Pens
- Variable vs Fixed Dosing
- Connected Pens
4. Important Pen-Delivered Drug Classes
- Antibodies
- Anticholinergics
- Dopamine Receptors
- Hematopoietics
- Human Growth Hormone
- Immune Modulators
- Insulins and Antihyperglycemics
- Parathyroid Hormone
- Reproductive Hormones
- Serotonin Antagonists
- Sympathomimetics
5. Pen Injectors - Therapeutic Sector Assessment
- Anemia
- Inflammatory Autoimmune Diseases
- Diabetes
- Emergency Medicine
- Hepatitis
- Hormone Replacement
- Osteoporosis
- Reproductive Health
- Other Commercial Pen Markets & Products
6. Market Factors
- Regulatory Considerations
- Patient Preferences and Compliance
- Managed Care Initiatives
- Private Labeling
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/kr66q6/pen_injection
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables , Needles and Syringes


Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 



